CN102940697B - 治疗过敏性鼻炎和支气管哮喘的药物 - Google Patents
治疗过敏性鼻炎和支气管哮喘的药物 Download PDFInfo
- Publication number
- CN102940697B CN102940697B CN201210536161.3A CN201210536161A CN102940697B CN 102940697 B CN102940697 B CN 102940697B CN 201210536161 A CN201210536161 A CN 201210536161A CN 102940697 B CN102940697 B CN 102940697B
- Authority
- CN
- China
- Prior art keywords
- allergic rhinitis
- bronchial asthma
- medicine
- aconiti lateralis
- lateralis preparata
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 208000006673 asthma Diseases 0.000 title claims abstract description 42
- 206010039085 Rhinitis allergic Diseases 0.000 title claims abstract description 36
- 201000010105 allergic rhinitis Diseases 0.000 title claims abstract description 36
- 239000003814 drug Substances 0.000 title claims abstract description 35
- 208000030603 inherited susceptibility to asthma Diseases 0.000 title claims abstract description 28
- 229940079593 drug Drugs 0.000 title description 6
- 238000002360 preparation method Methods 0.000 claims abstract description 8
- 239000000203 mixture Substances 0.000 claims description 9
- 239000012141 concentrate Substances 0.000 abstract description 6
- 239000000796 flavoring agent Substances 0.000 abstract description 4
- 235000019634 flavors Nutrition 0.000 abstract description 3
- 230000007774 longterm Effects 0.000 abstract description 2
- 241000173529 Aconitum napellus Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 229940023019 aconite Drugs 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 239000000706 filtrate Substances 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 238000000227 grinding Methods 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 31
- 208000024891 symptom Diseases 0.000 description 13
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 210000002345 respiratory system Anatomy 0.000 description 9
- 239000007788 liquid Substances 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 239000008187 granular material Substances 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 208000037656 Respiratory Sounds Diseases 0.000 description 4
- 206010047924 Wheezing Diseases 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000002685 pulmonary effect Effects 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 206010063659 Aversion Diseases 0.000 description 2
- 206010066091 Bronchial Hyperreactivity Diseases 0.000 description 2
- 208000019693 Lung disease Diseases 0.000 description 2
- 206010039101 Rhinorrhoea Diseases 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 208000037883 airway inflammation Diseases 0.000 description 2
- 210000005091 airway smooth muscle Anatomy 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000036427 bronchial hyperreactivity Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 210000003630 histaminocyte Anatomy 0.000 description 2
- 239000008473 mahuang fuzi xixin Substances 0.000 description 2
- 208000010753 nasal discharge Diseases 0.000 description 2
- 210000001331 nose Anatomy 0.000 description 2
- GYCKQBWUSACYIF-UHFFFAOYSA-N o-hydroxybenzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 241001671653 Aconitum carmichaelii Species 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 206010031123 Orthopnoea Diseases 0.000 description 1
- 206010070774 Respiratory tract oedema Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 230000036428 airway hyperreactivity Effects 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- CKMXBZGNNVIXHC-UHFFFAOYSA-L ammonium magnesium phosphate hexahydrate Chemical compound [NH4+].O.O.O.O.O.O.[Mg+2].[O-]P([O-])([O-])=O CKMXBZGNNVIXHC-UHFFFAOYSA-L 0.000 description 1
- 239000002269 analeptic agent Substances 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000000222 eosinocyte Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- -1 filter Substances 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 210000002850 nasal mucosa Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 208000012144 orthopnea Diseases 0.000 description 1
- 210000003889 oxyphil cell of parathyroid gland Anatomy 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 229910052567 struvite Inorganic materials 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210536161.3A CN102940697B (zh) | 2012-12-13 | 2012-12-13 | 治疗过敏性鼻炎和支气管哮喘的药物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210536161.3A CN102940697B (zh) | 2012-12-13 | 2012-12-13 | 治疗过敏性鼻炎和支气管哮喘的药物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102940697A CN102940697A (zh) | 2013-02-27 |
CN102940697B true CN102940697B (zh) | 2014-05-28 |
Family
ID=47723757
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210536161.3A Active CN102940697B (zh) | 2012-12-13 | 2012-12-13 | 治疗过敏性鼻炎和支气管哮喘的药物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102940697B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104001050A (zh) * | 2014-05-27 | 2014-08-27 | 马忠伟 | 治疗过敏性鼻炎的中药滴鼻剂 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1270759C (zh) * | 2004-04-02 | 2006-08-23 | 马登坤 | 一种治疗慢性鼻炎的苍辛膏及其制备方法 |
CN1724061A (zh) * | 2005-07-06 | 2006-01-25 | 王衡新 | 温中祛寒回阳救逆的中药制剂及其制备方法 |
KR20080083847A (ko) * | 2007-03-13 | 2008-09-19 | 장영미 | 피부질환 치료 조성물의 제조방법 |
CN101361953A (zh) * | 2008-09-22 | 2009-02-11 | 山西中医学院 | 四逆汤在制备治疗甲减性性功能降低的药物中的应用 |
CN102228582B (zh) * | 2011-06-24 | 2012-11-28 | 王仲举 | 一种治疗慢性气管炎、支气管炎引起的咳喘的药物 |
CN102552861A (zh) * | 2012-02-27 | 2012-07-11 | 吉林省中医药科学院 | 人参四逆颗粒剂及其制备方法 |
-
2012
- 2012-12-13 CN CN201210536161.3A patent/CN102940697B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN102940697A (zh) | 2013-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103933224A (zh) | 一种治疗痛风的中药组合物 | |
CN103142842B (zh) | 一种治疗糖尿病的中药 | |
CN103285119A (zh) | 一种治疗自身免疫性肝病的中药组合物及其制备方法 | |
CN103432485B (zh) | 一种治疗尿结石的中药制剂及制备方法 | |
CN102940697B (zh) | 治疗过敏性鼻炎和支气管哮喘的药物 | |
CN106539908A (zh) | 一种治疗过敏性鼻炎和皮肤过敏的中药组合物 | |
CN104435764A (zh) | 一种治疗糖尿病的中药组合物及其制备工艺 | |
CN103751349A (zh) | 一种治疗鼻炎的中药组合物及其制备方法 | |
CN103705772B (zh) | 一种抗炎保肝的中药组合物及其制备方法 | |
CN103585495B (zh) | 一种治疗糖尿病肾损害的胶囊 | |
CN105106634A (zh) | 一种治疗急性阑尾炎的中药制剂及其应用 | |
CN103845715A (zh) | 一种治疗慢性鼻炎的中药制剂 | |
CN105194165B (zh) | 一种用于泌尿系统感染的中药及制备方法 | |
CN103041362A (zh) | 一种治疗风湿、类风湿的药物及其制备方法 | |
CN103520538B (zh) | 一种治疗糖尿病引致肾脏损害的药物组合物 | |
CN104784567B (zh) | 一种治疗泌尿系感染的药物组合物 | |
CN105055788A (zh) | 一种治疗过敏性鼻炎的药物组合物 | |
CN105169009A (zh) | 一种中药组合物在制备治疗病毒性感冒药物中的应用 | |
CN104606377A (zh) | 一种治疗胃炎的中药组合物 | |
CN102961680B (zh) | 一种治疗胆结石、胆囊炎的中药制剂及其制备方法 | |
CN104906418B (zh) | 一种具有抗过敏作用的药物组合物 | |
CN104606426A (zh) | 一种治疗慢性胃炎的中药组合物制剂及其制备方法 | |
CN106138687A (zh) | 一种防治肾虚型哮喘的中药组合物 | |
CN104587122A (zh) | 一种治疗慢性胃炎的中药组合物 | |
CN103385909B (zh) | 一种治疗肝硬化腹水的药物组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 250014 Shandong city in Ji'nan Province, Lixia District ten Road No. 17079 three Qing Hui Wenxuan 1-1702 Patentee after: Shandong Zhonghong Kang Pharmaceutical Technology Development Co.,Ltd. Address before: Lixia District Hospital in Shandong province Ji'nan City Road 250014 No. 19 No. 4 West of Shandong Academy of Sciences Patentee before: JINAN KANGZHONG PHARMACEUTICAL TECHNOLOGY DEVELOPMENT Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20171227 Address after: 250014 Shandong province Ji'nan city Zhangqiu District Diao Zhen Industrial Economic Development Zone South of water field road to South Patentee after: Shandong Shengquan Kangzhong Pharmaceutical Co.,Ltd. Address before: 250014 Shandong city in Ji'nan Province, Lixia District ten Road No. 17079 three Qing Hui Wenxuan 1-1702 Patentee before: Shandong Zhonghong Kang Pharmaceutical Technology Development Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240408 Address after: Room 201, Building 12, Small and Medium sized Enterprise Industrialization Base, Biopharmaceutical Park, No. 1777 Dazheng Road, High tech Zone, Jinan City, Shandong Province, 250101 Patentee after: SHANDONG ZHONGDA PHARMACEUTICAL Co.,Ltd. Country or region after: China Address before: 250014 south of Shuitian Road, Diao Town Industrial Economic Development Zone, Zhangqiu District, Jinan City, Shandong Province Patentee before: Shandong Shengquan Kangzhong Pharmaceutical Co.,Ltd. Country or region before: China |